Continuing to accumulate, this is a fabulous company and paying a little more than what I first paid around $125-$130 on 5/2 and my initial recommendation on 3/1, but Novo will continue to scale even higher with its massive pipeline of novel diabetes and obesity drugs.
Categories
Trade Alert: Bought Novo Nordisk (NVO) $140
